# To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C714 and C714R in Healthy Adults

> **NCT06933459** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **AJU Pharm Co., Ltd.** · enrollment: 60 (actual)

## Conditions studied

- Dyslipidemia

## Interventions

- **DRUG:** Test Drug
- **DRUG:** Reference Drug

## Key facts

- **NCT ID:** NCT06933459
- **Lead sponsor:** AJU Pharm Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-05-24
- **Primary completion:** 2025-06-11
- **Final completion:** 2025-06-24
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06933459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06933459, "To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C714 and C714R in Healthy Adults". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06933459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*